Page 15 - 113中文衛福年報 有聲書

2024 Taiwan Health and Welfare Report Introduction

businesses, with a GHP inspection passed rate of over 99.9%. A
查核 13 萬 8,788 家次，食品良好
total of 520,000 food and related products were inspected and
衛生規範準則合格率為 99.9%；食
sampled, resulting in a pass rate of 99.6%.
品及相關產品標示查核及抽樣檢驗
52 萬件，合格率為 99.6%。 We actively enhance the regulatory framework for medicinal product
management, aligning it with international standards, to ensure
積極健全藥品管理法規，接軌國
the management of drug sources, quality, and safety monitoring,
際，落實藥品源頭管理、品質與
thereby safeguarding the public� s drug safety. We reinforced the
安全監測，保障民眾用藥安全。 flow management of controlled drugs and expanded the items

強化管制藥品流向管理及擴大列 being controlled. We implement anti-drug strategies, intensify
管品項；落實反毒策略，加強藥 efforts to prevent drug abuse, enhance inspections of imported
active pharmaceutical ingredients (APIs), and improve our testing
物濫用防制宣導及進口藥品原料
capabilities. Additionally, we continuously update medical device
藥查驗，提升檢驗量能。此外，
regulations and cosmetic hygiene and safety management standards
與時俱進修正醫療器材管理法規
to align with international practices. We lead the work and activities
及化粧品衛生安全管理規定，接
of international organizations on medical devices and cosmetics to
軌國際，主導醫療器材及化粧品 enhance international visibility.
國際組織工作及活動，提升國際
We continue to ensure that the manufacturing and distribution
能見度；持續確保藥品與醫療器
材製造與運銷作業符合國際PIC/S operations of drugs and medical devices comply with international
standards such as PIC/S GMP and ISO 13485. Furthermore, we
GMP及ISO13485 標準；並推動化
promote compliance with the Cosmetics Good Manufacturing
粧品製造場所符合化粧品優良製 Practice Guidelines (ISO22716 standard) for cosmetic manufacturing 07

造準則（ISO22716 標準）。另發布 facilities. Additionally, we have issued the "Regulations for the Post-
「上市中藥監測辦法」，112 年中 market Monitoring of Chinese Medicine Product," with a 92.7%
compliance rate for Chinese herbal materials and a 97.4% compliance
藥材合格率 92.7%，中藥製劑合
rate for Chinese herbal preparations in 2023. In September 2021, we
格率 97.4%。110 年 9 月公告臺
announced the fourth edition of the Taiwan Herbal Pharmacopoeia,
灣中藥典第四版，於 111 年出版
and the English version was published in 2022, enhancing the
英文版，精進中藥品質管理並與
quality management of Chinese herbal medicines and aligning with
國際接軌。 international standards.

因應管理各類產品需求，積極開
In response to the management of various product needs, we
發檢驗方法，112 年新增或修訂
have actively developed inspection methods. In 2023, we added,
檢驗方法達 56 篇，參與 28 場國 promulgated, amended, published or revised a total of 56 inspection
際共同研究或實驗室間能力比對， methods. We also participated in 28 international collaborative
research projects or laboratory proficiency testing programs,
獲國際肯定。另辦理食藥大數據
receiving international recognition. Furthermore, a competition
競賽，激發創新思考及突破思維，
on food and drug big data was organized to stimulate innovative
強化食品藥物安全危機處理之策
thinking and breakthroughs, strengthening the strategy formulation
略擬定及應變能力，運用新興媒
and response capabilities for food and drug safety crises. We
體FB及TFDA LINE@，即時傳播食 utilized emerging media platforms such as Facebook and the
藥醫粧知識及政策，提升民眾正 TFDA LINE@ to disseminate timely information on food, drugs,
確知能。 medical devices, and cosmetics, enhancing the public's knowledge
and understanding of relevant policies and promoting accurate
awareness among the public. 13